Tag: Sativex

GW Pharma Phase 3 Trials for Sativex Miss Endpoints

GW Pharmaceuticals and Otsuka Announce Results From Two Remaining Sativex(R) Phase 3 Cancer Pain Trials – Consistent with previously announced results from the initial Phase 3 trial, remaining trials...
- October 27th, 2015 at 8:53 am

GW Pharma's Sativex Treats MS Spasticity Successfully

BARCELONA — Multiple sclerosis patients taking the oromucosal cannabis-based spray called Sativex in routine practice to relieve spasticity are getting approximately the same degree of benefit expected from the...
- October 9th, 2015 at 11:48 am